Following FDA Approval Of Technology Transfer Process, Cytogam Manufactured By Co At Facility Now Available For Commercial Sales In U.S.
16/10/2023 12:14
Oct 16 (Reuters) - Kamada Ltd KMDA.TA :
* KAMADA LTD - FOLLOWING FDA APPROVAL OF TECHNOLOGY TRANSFER
PROCESS, CYTOGAM MANUFACTURED BY CO AT FACILITY NOW AVAILABLE
FOR COMMERCIAL SALES IN U.S.
* KAMADA LTD - COMPANY ESTABLISHES SCIENTIFIC ADVISORY BOARD
FOCUSED ON U.S. CLINICAL PROGRAMS FOR CYTOGAM
* KAMADA LTD - AVAILABILITY OF KAMADA-MANUFACTURED CYTOGAM
IN
CANADA IS EXPECTED LATER THIS YEAR
Source text for Eikon: ID:
Further company coverage: KMDA.TA
((Reuters.Briefs@thomsonreuters.com))
Recent news on Kamada
See all newsBrief: Kamada Updates On Withholding Tax Procedures On Previously Announced Cash Dividend To Shareholders
Brief: Kamada Announces Planned Transition Of Chief Financial Officer
Brief: Kamada Q2 EPS USD 0.16
Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
Brief: Kamada Q4 EPS USD 0.06